Evolution of therapeutic approaches for atopic dermatitis: a comparative analysis of current clinical guidelines
Vestnik dermatologii i venerologii · 29.09.2026 · 102 (4) · 25-32
DOI: 10.25208/vdv17032 ↗Kurz gefasst
Leitlinie in der Zeitschrift Vestnik dermatologii i venerologii, online erschienen am 29.09.2026. Verfasst von Marianna B. Drozhdina und 4 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The management of atopic dermatitis has evolved significantly in recent years due to the introduction of targeted biologics, Janus kinase (JAK) inhibitors, and novel topical therapies. This rapid progress necessitates regular updates to clinical guidelines and the revision of existing treatment algorithms. This review provides a comparative analysis of current clinical guidelines for the diagnosis and management of atopic dermatitis published between 2024 and 2025 in Japan, Canada, Korea, Europe, and Russia. Common trends were identified, and specific features in national approaches were highlighted. The analysis revealed that all reviewed guidelines reflect a paradigm shift from a predominantly stepwise treatment model to a personalized management strategy. This approach considers disease severity and extent, anatomic location, pruritus severity, impact on quality of life, patient age, comorbidities, and prior treatment response. While topical corticosteroids remain the cornerstone for managing acute flares, there is an increasing emphasis on topical nonsteroidal agents, maintenance regimens, and proactive therapy. For moderate-to-severe atopic dermatitis, advanced systemic targeted therapies, including biologics and JAK inhibitors, now occupy a central role. However, national guidelines diverge regarding specific diagnostic criteria, treatment sequencing, and recommendations for systemic corticosteroid use. These discrepancies are largely driven by regional healthcare standards and variations in drug accessibility. Thus, current guidelines demonstrate a shared focus on personalizing treatment, achieving long-term disease control, and improving patient quality of life.
Zitieren
APA
Drozhdina, M. B., Suslova, E. V., Lazviashvili, V. A., Zapivakhina, L. A., & Dekusar, N. S. (2026). Evolution of therapeutic approaches for atopic dermatitis: a comparative analysis of current clinical guidelines. Vestnik dermatologii i venerologii, 102(4), 25-32. https://doi.org/10.25208/vdv17032
Vancouver
Drozhdina MB, Suslova EV, Lazviashvili VA, Zapivakhina LA, Dekusar NS. Evolution of therapeutic approaches for atopic dermatitis: a comparative analysis of current clinical guidelines. Vestnik dermatologii i venerologii. 2026;102(4):25-32. doi:10.25208/vdv17032
BibTeX
@article{Drozhdina2026,
author = {Drozhdina, Marianna B. and Suslova, Elena V. and Lazviashvili, Varvara A. and Zapivakhina, Lada A. and Dekusar, Nikita S.},
title = {Evolution of therapeutic approaches for atopic dermatitis: a comparative analysis of current clinical guidelines},
journal = {Vestnik dermatologii i venerologii},
year = {2026},
volume = {102},
number = {4},
pages = {25--32},
doi = {10.25208/vdv17032}
}
EUVIMED